background
cancer
diagnost
surgeri
disrupt
respons
healthcar
servic
pandem
progress
cancer
delay
impact
patient
longterm
surviv
gener
perday
hazard
ratio
cancer
progress
observ
studi
appli
agespecif
stagespecif
cancer
surviv
england
model
perpati
delay
three
month
six
month
period
disrupt
one
year
two
year
use
healthcar
resourc
cost
contextualis
attribut
live
save
life
year
gain
cancer
surgeri
equival
volum
hospitalis
find
per
year
resect
major
cancer
result
longterm
survivor
life
year
gain
perpati
delay
six
month
would
caus
attribut
death
individu
loss
life
year
cancer
surgeri
averag
life
year
gain
lyg
per
patient
standard
condit
delay
six
month
loss
lyg
per
patient
take
account
unit
healthcar
resourc
hcru
surgeri
result
averag
per
patient
resourceadjust
life
year
gain
ralyg
standard
condit
ralyg
follow
delay
six
month
hospit
admiss
lyg
requir
hcru
hospitalis
communityacquir
patient
yield
averag
per
patient
lyg
ralyg
interpret
delay
six
month
surgeri
incid
cancer
would
mitig
life
year
gain
hospitalis
equival
volum
admiss
commun
acquir
rise
consid
resourceadjust
lifeyear
gain
avoid
downstream
public
health
crisi
avoid
cancer
death
cancer
diagnost
surgic
pathway
must
maintain
normal
throughput
rapid
attent
backlog
alreadi
accru
follow
first
case
report
hubei
provinc
china
late
pandem
coronaviru
declar
world
health
organis
march
whilst
caus
minim
mild
ill
small
appreci
proport
individu
requir
oxygen
therapi
often
admiss
intens
care
unit
icu
ensu
unpreced
pressur
hospit
ward
icu
necessit
rapid
repurpos
staff
capac
toward
manag
case
deprioritis
nonemerg
clinic
servic
includ
diagnost
elect
specialist
surgeri
concurr
lockdown
popul
led
reduct
present
referr
symptomat
patient
primari
secondari
care
mani
elect
procedur
ensur
delay
impact
qualiti
life
unlik
longterm
consequ
contrast
patient
cancer
delay
surgeri
real
potenti
increas
likelihood
metastat
diseas
patient
tumour
progress
curabl
near
normal
life
expect
noncur
limit
life
expect
situat
exacerb
recent
safeti
concern
regard
aerosol
gener
endoscopi
cystoscopi
surgeri
current
project
indic
disrupt
uk
healthcar
may
well
last
month
either
long
term
effect
contain
popul
largescal
vaccin
inform
healthcar
prioritis
resourc
alloc
period
requir
evalu
consequ
disrupt
diseaseassoci
mortal
specif
examin
impact
cancer
outcom
differ
period
delay
cancer
surgeri
disrupt
extend
variabl
time
period
compar
resourceweight
outcom
hospit
manag
patient
provid
research
polici
commun
public
baselin
paramet
surgic
case
volum
surviv
surgic
intervent
resourc
requir
pattern
adjuv
chemotherapi
assist
model
cancer
servic
ii
evidencebas
model
perday
cancer
progress
differ
tumour
type
iii
initi
estim
attribut
death
lost
actuari
life
year
agespecif
stagespecif
group
cancer
patient
perpati
delay
period
disrupt
iv
initi
estim
attribut
death
lost
actuari
life
year
sum
populationlevel
v
use
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
common
cost
healthcar
staf
initi
comparison
live
save
actuari
life
year
gain
compar
cancer
surgeri
hospitalis
patient
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
number
agespecif
surviv
cancer
patient
potenti
cur
surgic
resect
nonhaematolog
malign
obtain
public
health
england
nation
cancer
registr
servic
ncra
well
cancer
stage
diagnosi
cancer
type
breast
tumour
receptor
data
allow
subtyp
cancer
hormon
receptor
posit
er
median
durat
hospit
stay
cancer
type
staf
theatr
icu
surgic
ward
base
inform
three
larg
uk
surgic
oncolog
centr
pattern
administr
adjuv
system
anticanc
therapi
sact
base
oncologistreview
standard
practic
guidanc
icu
mortal
distribut
age
uk
obtain
icnarc
data
wuhan
use
basi
age
distribut
commun
infect
agespecif
likelihood
admiss
commun
hospit
mortal
rate
nonicu
patient
proport
hospit
patient
like
requir
icu
base
data
lombardi
requir
icu
stay
ward
day
respect
patient
base
hospit
admit
patient
care
activ
viral
pneumonia
well
critic
care
admiss
requir
advanc
respiratori
support
use
publish
data
impact
overal
surviv
delay
cancer
surgeri
estim
per
day
hazard
ratio
hr
mortal
associ
delay
differ
cancer
data
avail
given
cancer
assum
equival
hr
cancer
estim
could
gener
base
compar
survivorship
account
covidrel
postsurg
mortal
chang
sact
adjust
fiveyear
surviv
figur
cancer
surgic
patient
standard
care
estim
current
surviv
model
outcom
surgeri
postdelay
appli
standard
surviv
transit
hr
specifi
number
day
delay
includ
covidrel
postsurg
mortal
chang
sact
estim
covidassoci
surgic
mortal
base
per
day
rate
nosocomi
infect
operationspecif
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
durat
postsurg
admiss
agespecif
mortal
infect
cancer
routin
treat
sact
estim
associ
mortal
base
per
day
rate
nosocomi
infect
frequenc
sact
schedul
increas
risk
associ
immunosuppress
agespecif
mortal
infect
assum
improv
cold
protocol
model
differ
rate
nosocomi
current
postdelay
surgeri
model
assum
sact
administ
benefit
exce
covidrel
mortal
use
actuari
lifeexpect
calcul
life
year
gain
averag
per
patient
examin
reduct
overal
surviv
os
life
year
gain
lyg
compar
surgeri
standard
care
current
condit
postdelay
cancer
type
age
stage
use
surgic
workload
data
calcul
across
adult
cancer
examin
total
number
death
life
year
lost
attribut
delay
address
possibl
scenario
consid
perpati
delay
period
disrupt
compar
life
year
associ
time
cancer
surgeri
afford
hospitalis
patient
model
communityascertain
infect
age
adjust
demograph
differ
england
wuhan
appli
agespecif
rate
admiss
commun
case
hospit
assum
hospit
patient
transfer
icu
appli
estim
agespecif
surviv
icu
patient
icnarc
nonicu
patient
use
data
wuhan
calcul
attribut
life
year
gain
hospitalis
base
analysi
agespecif
surviv
nonadmiss
zero
icu
nonicu
analys
healthcar
resourc
unit
hcru
focus
specif
frontlin
medic
nurs
staff
one
hcru
one
shift
direct
nurs
medic
care
upweight
shift
healthcar
worker
highsalari
senior
doctor
andor
current
scarciti
anaesthetist
icu
nurs
calcul
hcru
per
patient
use
estim
staf
ratio
theatr
icu
ward
care
operationspecif
data
theatr
hour
icu
stay
ward
day
oncolog
centr
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
analys
perform
use
stata
version
transcrib
excel
provid
full
visibl
parametris
model
output
opportun
reader
customis
paramet
supplementari
materi
fund
sourc
part
studi
design
collect
data
analysi
interpret
data
write
report
decis
submit
manuscript
correspond
author
full
access
data
studi
final
decis
submit
manuscript
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
greatest
rate
death
aris
follow
even
modest
delay
surgeri
aggress
cancer
reduct
surviv
six
month
reduct
surviv
three
month
patient
stage
cancer
bladder
lung
oesophagu
ovari
liver
pancrea
stomach
high
proport
solid
cancer
surviv
year
gener
consid
equival
cure
predic
assert
consid
gain
actuari
life
year
gain
adjust
resourc
resourc
adjust
life
year
ralyg
perhap
surprisingli
benefit
afford
younger
age
group
oper
shorter
associ
icu
requir
exampl
tran
urethr
resect
stage
bladder
cancer
afford
averag
ralyg
per
patient
age
wherea
cystectomi
stage
bladder
cancer
associ
ralyg
age
group
supplementari
tabl
context
prioritis
avoid
delay
restitut
averag
ralyg
former
group
compar
latter
tabl
supplementari
tabl
wide
local
excis
breast
cancer
low
resourc
requir
therefor
confer
substanti
ralyg
even
good
prognosi
subtyp
year
surgic
resect
common
invas
adult
cancer
type
undertaken
england
patient
surviv
cancer
year
surgic
delay
three
month
across
incid
solid
tumour
one
year
would
incur
excess
death
escal
excess
death
six
month
delay
includ
six
month
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
attribut
death
colorect
cancer
lung
cancer
breast
cancer
figur
high
proport
solid
cancer
surviv
gener
consid
equival
cure
predic
assert
across
cancer
delay
three
month
treatment
would
lead
reduct
lifeyear
six
month
reduct
life
year
tabl
figur
show
respect
long
term
consequ
delay
differ
cancer
type
prior
crisi
year
cancer
surgeri
directli
respons
lyg
repres
averag
lyg
per
patient
markedli
reduc
three
month
delay
six
month
delay
cancer
surgeri
per
year
requir
unit
healthcar
resourc
assum
unchang
delay
afford
averag
ralyg
per
patient
standard
condit
reduc
three
month
delay
six
month
delay
averag
loss
ralyg
respect
per
patient
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
therefor
noteworthi
delay
surgeri
six
month
result
lost
life
year
annual
quota
surgic
patient
equat
total
life
year
gain
hospitalis
equival
number
communityacquir
case
rise
adjust
differ
resourc
ralyg
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
whilst
seek
gener
minimis
social
contact
prompt
present
primari
care
evalu
investig
new
symptom
remain
essenti
order
offer
best
opportun
cur
surgeri
cancer
signific
proport
patient
delay
month
diagnosi
surgeri
affect
likelihood
achiev
longterm
surviv
cancer
aggress
cancer
even
short
delay
three
month
signific
impact
patient
surviv
howev
even
cancer
compar
favour
prognosi
moder
delay
six
month
result
signific
sum
attribut
death
mani
cancer
common
delay
also
result
tumour
advanc
mean
surviv
poorer
upstag
cancer
costli
treat
term
surgeri
andor
chemotherapi
furthermor
resourc
requir
exampl
icu
stay
dramat
higher
mani
inevit
present
emerg
obstruct
perfor
acut
bleed
gastrointestin
tract
alongsid
bulg
accumul
case
normal
stream
incid
cancer
present
face
prolong
stress
challeng
provid
extra
capac
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
address
bulg
alongsid
standard
demand
real
danger
shall
find
backlog
initi
crisi
caus
knockon
delay
affect
deliveri
cancer
diagnost
surgeri
sever
year
result
substanti
excess
death
need
consid
resourc
like
event
need
maintain
provis
treat
sustain
period
time
potenti
year
although
larg
facil
may
builtrepurpos
manag
facil
compet
fix
pool
healthcar
worker
provid
care
treat
diseas
compar
analys
demonstr
sizeabl
drop
cancer
surviv
result
short
three
month
moder
six
month
delay
treatment
delay
cancer
surgeri
highli
deleteri
health
econom
impact
part
surgeri
still
requir
may
complex
costli
result
rapid
diminut
result
life
year
gain
resourceadjust
life
year
compar
equival
size
hospit
popul
adjust
resourc
health
impact
delay
cancer
surgeri
six
month
approxim
health
gain
hospit
commun
acquir
infect
use
data
england
cancer
surviv
broadli
similar
across
econom
develop
countri
impact
delay
per
tumour
broadli
applic
howev
variat
incid
cancer
actuari
surviv
popul
structur
mean
predict
regard
total
case
number
life
year
gain
lost
difficult
extrapol
even
scale
rel
size
refer
popul
mediumlong
term
next
month
avoid
delay
cancer
surgeri
highest
prioriti
urgent
attent
requir
ensur
suffici
resourc
standard
capac
cancer
diagnost
surgic
pathway
short
term
avoid
knockon
delay
immedi
divers
supranorm
resourc
volum
requir
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
process
backlog
case
accru
initi
month
pandem
referr
investig
surgeri
reduc
activ
focu
requir
establish
cold
section
healthcar
system
rigor
protocol
staff
screen
shield
protocol
serv
minimis
nosocomi
acquisit
mortal
protect
staff
also
provid
reassur
public
regard
uptak
diagnost
surgeri
cancer
urgent
review
profession
bodi
requir
regard
best
protect
staf
group
guidanc
surgic
diagnost
practic
commensur
true
risk
recent
guidanc
issu
nh
england
assign
three
level
prioriti
surgic
treatment
noncoronaviru
cancer
patient
emerg
within
hour
urgent
requir
within
week
save
lifeprev
progress
diseas
beyond
oper
nonurg
delay
week
predict
neg
outcom
howev
presum
incorrect
assumpt
covidrel
disrupt
servic
fulli
resolv
within
week
nearli
nonemerg
cancer
case
schema
urgent
categori
profession
group
issu
specif
tumourtyp
guidanc
given
accru
backlog
case
ongo
tight
competit
resourc
inevit
decis
regard
surgic
prioritis
requir
number
year
capac
vari
geograph
tempor
recognis
limit
regard
assumpt
paramet
propos
model
provid
ration
approach
evalu
across
patient
differ
age
tumour
type
stage
benefit
resourc
implic
cancer
surgeri
highlight
model
agestag
group
covidrel
mortal
current
exce
surviv
benefit
surgeri
andor
sact
whilst
group
benefit
margin
rational
delay
nevertheless
requir
monitor
surgeri
downstream
longitudin
plan
monitor
progress
dynam
reprioritis
capacityplan
inevit
highli
challeng
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
within
current
approach
estim
effect
specifi
period
perpati
delay
data
nh
activ
last
month
offer
prospect
develop
dynam
model
predict
impact
differenti
prioritis
patient
group
ii
differ
pattern
represent
accumul
case
alongsid
incid
case
iii
vari
releas
bottleneck
primari
care
diagnost
surgeri
evalu
also
import
altern
manag
approach
adopt
radiotherapi
cur
intent
surgeri
goldstandard
priori
hormon
treatment
prostat
erposit
breast
cancer
strategi
involv
deliber
delay
surgeri
model
restag
dynam
reprioritis
essenti
focus
impact
surgeri
cur
intent
analys
also
requir
quantifi
impact
mortal
withhold
lifeextend
chemoand
radiotherapi
patient
stage
diseas
compar
resourceadjust
outcom
cancer
surgeri
hospitalis
communityacquir
infect
systemat
resourceadjust
outcom
analysi
across
aspect
healthcar
would
serv
inform
compet
prioriti
broadli
assum
univers
contract
avail
resourc
non
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
healthcar
healtheconom
reevalu
cancer
care
protocol
bee
requir
avail
treatment
high
cost
per
qali
like
requir
review
decis
regard
prioritis
ringfenc
healthcar
capac
need
evidencebas
ensur
health
benefit
hospitalis
communityacquir
infect
ultim
dwarf
consequ
delay
manag
patient
cancer
lifethr
diseas
rapid
compar
impact
analys
requir
compar
manag
cancer
surgeri
highli
impact
regard
lifeyear
gain
per
resourc
expend
delay
diagnosi
surgeri
caus
exponenti
burden
attribut
mortal
pandem
place
unpreced
strain
health
care
provis
highli
plausibl
pressur
continu
two
year
supranorm
capac
requir
address
backlog
accumul
cancer
case
alongsid
ongo
incid
case
avoid
defer
public
health
crisi
unnecessari
cancer
death
urgent
ringfenc
substanti
resourc
requir
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
surgeri
six
month
delay
indic
strata
estim
lower
confid
wherebi
crude
rather
net
surviv
estim
appli
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
declar
compet
interest
coronaviru
diseas
result
disrupt
elect
medic
servic
includ
diagnost
surgeri
cancer
deliv
outcom
cancer
treatment
influenc
nosocomi
infect
variou
observ
studi
inher
confound
indic
studi
differ
tumour
type
impact
delay
diagnosi
longterm
surviv
systemat
evalu
impact
surviv
global
delay
surgeri
individu
tumour
type
sum
across
tumour
type
standardis
analysi
surviv
compar
hospitalis
commun
acquir
cancer
surgeri
knowledg
provid
first
explicit
analysi
impact
longterm
surviv
differ
perpati
delay
surgeri
combin
detail
data
cancer
surgeri
england
nation
cancer
registr
analysi
servic
perday
hazard
ratio
cancer
progress
observ
studi
quantifi
impact
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
differ
period
perpati
delay
cancer
surviv
agespecif
stagespecif
individu
tumour
group
sum
popul
level
differ
durat
disrupt
found
delay
three
month
caus
substanti
impact
surviv
mani
tumour
group
adjust
resourc
reduct
total
surviv
result
sixthmonth
per
patient
delay
cancer
surgeri
approach
magnitud
surviv
gain
hospitalis
equival
number
communityacquir
infect
substanti
backlog
cancer
case
alreadi
accru
account
reluct
patient
seek
healthcar
disrupt
primari
care
divers
staff
cancer
diagnost
surgeri
concern
safeti
procedur
supranorm
capac
requir
address
swiftli
accumul
backlog
failur
ringfenc
capac
backlog
maintain
rapid
pathway
cancer
diagnosi
surgeri
result
sizeabl
delay
public
health
crisi
avoid
cancer
death
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
tabl
reduct
surviv
consequ
sixmonth
delay
surgeri
cancer
type
tumour
stage
age
diagnosi
indic
strata
estim
lower
confid
wherebi
crude
rather
net
surviv
estim
appli
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
tabl
estim
averag
life
year
gain
per
unit
healthcar
resourc
cancer
surgeri
tumour
stage
age
diagnosi
cancer
type
compar
current
surgeri
surgeri
six
month
delay
indic
strata
estim
lower
confid
wherebi
crude
rather
net
surviv
estim
appli
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
clinic
guid
manag
noncoronaviru
patient
requir
acut
treatment
cancer
specialti
guid
patient
manag
coronaviru
pandem
nh
england
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
